PUI
BEAM icon

Purpose Unlimited Inc’s Beam Therapeutics BEAM Stock Holding History

Purpose Unlimited Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,894
Closed -$80.2K – 584
2025
Q4 		$80.2K Buy
+2,894
New +$73.8K ﹤0.01% 224

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Purpose Unlimited Inc's BEAM Position: Q1 2026 in Review

Purpose Unlimited Inc sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 2,894 shares — an estimated $80.2K sold.

Purpose Unlimited Inc first reported a position in BEAM in Q4 2025 and held it in 1 quarter. The position peaked at $80.2K in Q4 2025. 252 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Purpose Unlimited Inc reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Purpose Unlimited Inc sold 2,894 Beam Therapeutics shares in Q1 2026, an estimated $80.2K.
  • Purpose Unlimited Inc first reported a position in Beam Therapeutics in Q4 2025 and held it in 1 quarter.
  • Purpose Unlimited Inc's Beam Therapeutics position peaked at $80.2K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Purpose Unlimited Inc's 13F filing for Q1 2026, filed 15 May 2026.